Immune aspects of the pathogenesis of inflammatory bowel disease.
about
Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in miceDefective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patients16S sequencing and functional analysis of the fecal microbiome during treatment of newly diagnosed pediatric inflammatory bowel disease.Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems.Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel diseaseInfluence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetesCyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli.Phosphoethanolamine Modification of Neisseria gonorrhoeae Lipid A Reduces Autophagy Flux in MacrophagesIntestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes.B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitisImmunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes.New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review.Implication of miRNAs for inflammatory bowel disease treatment: Systematic review.The emerging role of circulating microRNAs as biomarkers in autoimmune diseases.Biological therapy for ulcerative colitis: an update.Regenerative inflammation: lessons from Drosophila intestinal epithelium in health and disease.Control of autoimmune inflammation by celastrol, a natural triterpenoid.Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitis.The Immunological Basis of Inflammatory Bowel DiseaseBasiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient.MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.Effects of the Sijunzi decoction on the immunological function in rats with dextran sulfate-induced ulcerative colitis.Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype.Resveratrol Role in Autoimmune Disease-A Mini-Review.TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice.Granulomatous enteritis in rainbow trout (Oncorhynchus mykiss) associated with soya bean meal regardless of water dissolved oxygen level.1,25-dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 and Th17 activation.Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis.FKBP11 protects intestinal epithelial cells against inflammation‑induced apoptosis via the JNK‑caspase pathway in Crohn's disease
P2860
Q33608698-9D3F4A3F-61A7-4FE1-8173-59E783207CA0Q33699974-E4F75CE6-B8F6-4E50-8625-A0EC46238768Q33879834-465E2F8D-A68C-41DF-9B12-B2B8F946322AQ34143148-021846E2-C5DF-4B61-9364-BFA22858C05FQ34499080-53625509-9786-480C-A8CC-B91ACD1E5B75Q34827250-F65FDB29-D2DF-4797-ACB7-045393E5F190Q35055599-F460FB96-C2E0-448F-BF4A-BF7DA991D281Q35417757-3970FC7F-85C0-4299-9F9A-8FC21BF6AE52Q35862098-0CA483BE-3717-4394-BB34-49AC9B561DC9Q35898522-B10B2E32-0CE5-435B-A15C-91E80DF5E6D1Q36088901-DEB13E7E-E3ED-4352-90B8-01026A4E024BQ36393719-841F4AC2-81DE-49B6-BD66-F76C0FFC0BB6Q37552125-21C4D6C3-839B-4A14-8900-2DC29945C688Q38110619-CAD2BFFB-3D96-42AF-93A9-8525EFEEEE8AQ38201788-4FE76D6D-6C6D-477B-B4C4-EF1EC065E0DEQ38217235-2E4AB4AE-0189-498B-833C-E93A8AAA7F51Q38222306-A3D94CE9-0030-4EAA-B1BE-A16D54D2F586Q38259532-29248AAB-417B-4CAC-A359-EAD5545860BDQ38273211-001352B4-5075-4BFD-B9C0-FB78C0BDB6C7Q38894091-A6BEE92C-E315-41F5-B373-46B29C03D686Q39007497-F3D2086B-9603-4F6B-AFAD-95B4E30BD63AQ39077548-2949E328-E6DE-4929-9199-C0A73D3B5522Q40139185-778F4470-4C34-401D-8F1A-7C266CDB90A0Q41334648-3DEA41F1-7E2F-442A-996A-3161CDE55C8DQ41847686-724563A7-2F51-46DD-8C55-9D2526462388Q42030296-F69DF622-33F0-43F7-852C-CA6283E152EDQ47158536-F8FE4A86-D216-46FE-BDB6-326A4C115410Q47725450-4E4040B9-CDCB-4393-837D-61FDAAA62AF4Q47872149-F2517CE0-E6ED-4266-9620-A355C1769DDDQ50447257-FACDE2E3-73BB-4075-8AF5-2C59375BC249Q54936999-2CD5DDF3-6871-4F76-846F-F859FD3BDEC9Q58738376-6BAF6D11-2D0B-4FC3-B7C3-9ADF51F1F0D3
P2860
Immune aspects of the pathogenesis of inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune aspects of the pathogenesis of inflammatory bowel disease.
@en
type
label
Immune aspects of the pathogenesis of inflammatory bowel disease.
@en
prefLabel
Immune aspects of the pathogenesis of inflammatory bowel disease.
@en
P2093
P921
P1476
Immune aspects of the pathogenesis of inflammatory bowel disease
@en
P2093
Katsuyoshi Matsuoka
Kazuaki Yoneno
Tadakazu Hisamatsu
Takanori Kanai
Toshifumi Hibi
P304
P356
10.1016/J.PHARMTHERA.2012.10.008
P50
P577
2012-10-26T00:00:00Z